Ingevity (NYSE:NGVT) Issues FY 2026 Earnings Guidance

Ingevity (NYSE:NGVT) updated its FY 2026 earnings guidance on Wednesday. The company provided EPS guidance of 4.700-5.200 for the period, compared to the consensus EPS estimate of 4.850. The company issued revenue guidance of $1.1 billion-$1.2 billion, compared to the consensus revenue estimate of $1.2 billion.

Analysts Set New Price Targets

Several research analysts have weighed in on the stock. Wall Street Zen cut shares of Ingevity from a “buy” rating to a “hold” rating in a report on Saturday, April 4th. Wells Fargo & Company increased their price target on shares of Ingevity from $65.00 to $75.00 and gave the company an “equal weight” rating in a report on Friday, February 27th. Jefferies Financial Group restated a “buy” rating and set a $82.00 target price on shares of Ingevity in a research report on Thursday, February 26th. Weiss Ratings restated a “sell (d-)” rating on shares of Ingevity in a research report on Tuesday, April 21st. Finally, BMO Capital Markets restated an “outperform” rating and set a $83.00 target price on shares of Ingevity in a research report on Monday, March 2nd. Two equities research analysts have rated the stock with a Buy rating, two have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus target price of $80.00.

Ingevity Price Performance

Shares of NYSE NGVT traded down $3.56 during trading hours on Thursday, hitting $74.32. 205,845 shares of the stock were exchanged, compared to its average volume of 311,152. Ingevity has a 1-year low of $39.17 and a 1-year high of $79.29. The company has a debt-to-equity ratio of 39.10, a quick ratio of 0.79 and a current ratio of 1.33. The company has a market cap of $2.62 billion, a PE ratio of -16.12 and a beta of 1.24. The company’s fifty day simple moving average is $71.14 and its two-hundred day simple moving average is $64.01.

Ingevity (NYSE:NGVT) last issued its earnings results on Wednesday, May 6th. The company reported $1.15 earnings per share for the quarter, beating analysts’ consensus estimates of $0.84 by $0.31. Ingevity had a negative net margin of 13.51% and a positive return on equity of 126.25%. The firm had revenue of $258.00 million for the quarter, compared to analyst estimates of $254.73 million. During the same quarter last year, the business posted $1.01 earnings per share. The company’s quarterly revenue was up 4.1% on a year-over-year basis. Ingevity has set its FY 2026 guidance at 4.700-5.200 EPS. On average, sell-side analysts predict that Ingevity will post 5.05 EPS for the current year.

Institutional Trading of Ingevity

Hedge funds have recently added to or reduced their stakes in the stock. Advisory Services Network LLC lifted its holdings in shares of Ingevity by 4.4% during the third quarter. Advisory Services Network LLC now owns 6,947 shares of the company’s stock worth $383,000 after purchasing an additional 293 shares during the period. Amundi lifted its holdings in shares of Ingevity by 4.8% during the third quarter. Amundi now owns 6,626 shares of the company’s stock worth $364,000 after purchasing an additional 302 shares during the period. Geneos Wealth Management Inc. lifted its holdings in shares of Ingevity by 85.8% during the second quarter. Geneos Wealth Management Inc. now owns 838 shares of the company’s stock worth $36,000 after purchasing an additional 387 shares during the period. Global Retirement Partners LLC acquired a new position in shares of Ingevity during the fourth quarter worth $27,000. Finally, CANADA LIFE ASSURANCE Co lifted its holdings in shares of Ingevity by 1.6% during the fourth quarter. CANADA LIFE ASSURANCE Co now owns 30,116 shares of the company’s stock worth $1,782,000 after purchasing an additional 485 shares during the period. Institutional investors and hedge funds own 91.59% of the company’s stock.

Ingevity Company Profile

Ingevity Corporation, traded as NGVT, is a specialty chemicals and performance materials company headquartered in North Charleston, South Carolina. The company operates two primary business units: Performance Chemicals and Performance Materials. The Performance Chemicals segment produces and markets specialty chemicals derived largely from wood and other natural feedstocks, including rosin acids, tall oil fatty acids and esters, as well as specialty petroleum resins. These products serve a broad range of industries, including paper, adhesives, coatings, oilfield drilling and consumer goods.

The Performance Materials segment develops and manufactures activated carbon products and composites for applications such as automotive emissions control, industrial air and water purification, and spill containment.